Zenyatta Announces New Research Collaboration on Graphene Composites with German Aerospace Center

Zenyatta Ventures Ltd. (TSXV: ZEN, “Zenyatta” or the “Company”) today announced that it will be commencing a new research collaboration with the University of British Columbia (UBC)‐Okanagan Campus and the Deutsches Zentrum für Luft‐ und Raumfahrt (“DLR”, the German Aerospace Center) to investigate the potential use of Albany Graphite for graphene and graphene oxide in new composite materials. The composite development project will be led by Dr. Lukas Bichler. “UBC researchers have established a partnership with DLR, which seeks to provide unique educational and research opportunities for future engineers. Also, the partners bring together Canadian and European industry partners and allow effective technology transfer and rapid innovation”, said Dr. Bichler. “A partnership with Zenyatta, DLR and UBC researchers is truly a very exciting opportunity to lead in the development of the next‐generation composite materials. Separately, Zenyatta will also be working with UBC on a graphene oxide fuel additive. Research has found that graphene oxide can improve fuel economy by 7.5%, and potentially reduce emissions by 8% while increasing power by 10%. Dr. Sina Kheirkhah, a combustion engineer, will be the lead researcher for the fuel additive project. Dr. Sina Kheirkhah commented that “Graphene oxide is a carbon‐ and oxygen‐rich nanomaterial which can potentially increase the combustion ratewhen added to jet fuel. Graphene‐doping also has the potential to boost aircraft propulsive force and increase the power of land‐based gas turbines.” Dr. Francis Dubé, Zenyatta’s Co‐CEO and Head of Business Development and Technology said: “This model of collaboration between Zenyatta, potential end users, like DLR, matched with research partners, like Dr. Bichler, can lead to exciting new inventions. It is a model that we will endeavor to repeat with other end users and university researchers.” The German Aerospace Center (DLR) is the national aeronautics and space research centre of the Federal Republic of Germany. Its extensive research and development work in aeronautics, space, energy, transport, digitalization and security is integrated into national and international cooperative ventures. In addition to its own research, as Germany’s space agency, DLR has been given responsibility by the federal government for the planning and implementation of the German space program. DLR is also the umbrella organization for one of Germany’s largest project management agencies. DLR has approximately 8000 employees at 20 locations in Germany, and has offices in Brussels, Paris, Tokyo and Washington D.C. Zenyatta and its research partners will continue with innovative product development work to potentially create value for shareholders through IP protected inventions. Zenyatta also intends to work with other leading industrial partners to co‐develop IP. One of the important goals of the Company is to become an IP incubator where it can participate in IP creation across multiple industry sectors. Mr. Peter Wood, P.Eng, P.Geo., President and COO of Zenyatta, is the “Qualified Person” for the purposes of National Instrument 43‐101 and has reviewed, prepared and supervised the preparation of the technical information contained in this news release. For further information: Dr. Francis Dubé, Co‐CEO & Head of Business Development and Technology Tel: +1 (289) 821‐2820 Email: fdube@zenyatta.ca
  • Share

About Zentek Ltd.

Zentek is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection and treatment. Zentek is currently focused on commercializing ZenGUARD™, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases. The company also has an exclusive agreement to be the global commercializing partner for a newly developed, highly scalable, aptamer-based rapid pathogen detection technology.

To find out more about Zentek Ltd., please visit our website at www.zentek.com. A copy of this news release and all material documents in respect of the Company may be obtained on Zentek's SEDAR profile at www.sedar.com.

Forward-Looking Statements

This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information:

Tyler Dunn

Director, Marketing & Communications

tdunn@zentek.com

Subscribe for Updates

Interested in recieving press releases directly to your inbox? Subscribe to Zentek's mailing list for all the latest news.